Financials
- Market Capitalization 28.95 M
- Employee 12
- Founded 2016
- CEO N/A
- Website www.transcodetherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00ZGYHV03
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.13
Relación precio/flujo de caja
-42.04
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4365 | NXTC NextCure, Inc. - Common Stock | 6.78 USD | +3.35% | +31.14% | -15.14% | -48.24% | 31.03 M USD | ||
| 4372 | QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 USD | +9.88% | -2.78% | -2.13% | +1298.10% | 29.86 M USD | ||
| 4383 | IGC IGC Pharma, Inc. Common Stock | 0.28 USD | 0.00% | 0.00% | 0.00% | +9.29% | 28.95 M USD | ||
| 4394 | CNTX Context Therapeutics Inc. - Common Stock | 0.30 USD | -3.23% | -3.23% | -18.92% | -79.59% | 27.56 M USD |